Get started
Author

Michael B. Brown

Observed name: Brown, Michael B.
Observed institution: Springer Nature (New Zealand)
ORCID: 0009-0008-5649-5651
Observed ORCID: 0009-0008-5649-5651
OpenAlex ID: A5084605121
Tegileridine in postoperative pain: a profile of its use
2025 · Michael B. Brown, Yahiya Y. Syed · Drugs & Therapy Perspectives · 3
CT-P39: An Omalizumab Biosimilar
2025 · Michael B. Brown · Clinical Drug Investigation · 2
Iptacopan in paroxysmal nocturnal haemoglobinuria: a profile of its use
2025 · Michael B. Brown, Matt Shirley · Drugs & Therapy Perspectives · 1
Clesrovimab in prevention of RSV lower respiratory tract disease: a profile of its use in infants
2026 · Michael B. Brown, Yahiya Y. Syed · Drugs & Therapy Perspectives
PDF
Personalize statin therapy following acute ischemic stroke
2026 · Michael B. Brown · Drugs & Therapy Perspectives
PDF
Axatilimab (Niktimvo®) in chronic graft-versus-host disease: a profile of its use
2026 · Michael B. Brown, Hannah A. Blair · Drugs & Therapy Perspectives
PDF
Take a personalised approach to weight management for older adults with obesity
2026 · Michael B. Brown · Drugs & Therapy Perspectives
PDF
Apremilast in moderate to severe plaque psoriasis: a profile of its use in paediatric patients
2025 · Michael B. Brown, Matt Shirley · Drugs & Therapy Perspectives
Use established and emerging analgesics for acute pain management while new therapies are in development
2025 · Michael B. Brown · Drugs & Therapy Perspectives
Consider co-occurring conditions when selecting pharmacological treatment options for binge eating disorder
2025 · Michael B. Brown · Drugs & Therapy Perspectives
Use standard and enhanced vaccines to prevent influenza, while new classes remain in development
2025 · Michael B. Brown · Drugs & Therapy Perspectives
Take a personalised approach when treating older adults with rosacea
2025 · Michael B. Brown, Sheridan M. Hoy · Drugs & Therapy Perspectives
Works count: 14
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type